Dr Reddy’s Laboratories

Dr Reddy’s announces launch of Colchicine Tablets USP in the US

Read more

Dr Reddy’s Laboratories completes acquisition of Wockhardt’s select business divisions

Read more

Dr Reddy’s PAT up 76 per cent in Q4, soft-launches HCQ in India

Read more

Dr Reddy’s recalls its heart burn medicine in the US

Read more

Dr Reddy’s gets EIR from USFDA for Srikakulam plant

Read more

Dr Reddy’s launches generic lipid-regulating tablets in US

Read more

Dr Reddy’s launches generic opioid antagonist injection in US

Read more

Dr Reddy’s launches generic Ziprasidone Mesylate for injection in US

Read more

Satish Reddy elected CII SR Chairman

Read more

Female workforce in pharma: Knocking on the glass ceiling?

Read more